NuVasive Sees Increased Volume and Demand in Second Quarter

NuVasive reported 2Q22 orthopedic sales of $310.5 million, +5.3% vs. 2Q21.

While facing the same macroeconomic pressures as its peers, NuVasive saw procedure volumes increase and a surge in demand for its products. Much of that volume growth came in areas where the company had little to no prior business, like cervical. NuVasive leadership...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us